Host cell cathepsins potentiate moloney murine leukemia virus infection

Journal of Virology

Volumn 81, Issue 19, 2007, Pages 10506-10514

  Kumar, Pankaj ^a   Nachagari, Deepa ^a   Fields, Carolyn ^a   Franks, John ^a   Albritton, Lorraine M ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALOXISTATIN; CATHEPSIN; CATHEPSIN B; CATHEPSIN III INHIBITOR; CYSTEINE PROTEINASE INHIBITOR; ENVELOPE PROTEIN; PROTEINASE; THROMBOSPONDIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; FIBROBLAST; HOST CELL; LYSOSOME; MEMBRANE FUSION; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; SYNCYTIUM; VESICULAR STOMATITIS VIRUS; VIRUS ENVELOPE; VIRUS INFECTION; VIRUS PARTICLE; WESTERN BLOTTING;

ANIMALS; CATHEPSIN B; CYSTEINE PROTEINASE INHIBITORS; DIPEPTIDES; ENDOCYTOSIS; LEUCINE; LEUKEMIA, EXPERIMENTAL; LYSOSOMES; MEMBRANE FUSION; MICE; MOLONEY MURINE LEUKEMIA VIRUS; NIH 3T3 CELLS;

MOLONEY MURINE LEUKEMIA VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 34648830868     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02853-06     Document Type: Article

References (31)

1. Andersen, K. B. 1987. Cleavage fragments of the retrovirus surface protein gp70 during virus entry. J. Gen. Virol. 68:2193-2202.
2. Andersen, K. B. 1983. Leupeptin inhibits retrovirus infection in mouse fibroblasts. J. Virol. 48:765-769.
3. Andersen, K. B., and B. A. Nexo. 1983. Entry of murine retrovirus into mouse fibroblasts. Virology 125:85-98.
4. Andersen, K. B., and H. Skov. 1989. Retrovirus-induced cell fusion is enhanced by protease treatment. J. Gen. Virol. 70:1921-1927.
5. Bacheler, L., and H. Fan. 1981. Isolation of recombinant DNA clones carrying complete integrated proviruses of Moloney murine leukemia virus. J. Virol. 37:181-190.
6. Battini, J. L., O. Danos, and J. M. Heard. 1995. Receptor-binding domain of murine leukemia virus envelope glycoproteins. J. Virol. 69:713-719.
7. Buttle, D. J., M. Murata, C. G. Knight, and A. J. Barrett. 1992. CA074 methyl ester: a proinhibitor for intracellular cathepsin B. Arch. Biochem. Biophys. 299:377-380.
8. Chandran, K., N. J. Sullivan, U. Felbor, S. P. Whelan, and J. M. Cunningham. 2005. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308:1643-1645.
9. Chu, T. H., and R. Dornburg. 1997. Toward highly efficient cell-type-specific gene transfer with retroviral vectors displaying single-chain antibodies. J. Virol. 71:720-725.
10. Davey, R. A., C. A. Hamson, J. J. Healey, and J. M. Cunningham. 1997. In vitro binding of purified murine ecotropic retrovirus envelope surface protein to its receptor, MCAT-1. J. Virol. 71:8096-8102.
11. Ebert, D. H., J. Deussing, C. Peters, and T. S. Dermody. 2002. Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells. J. Biol. Chem. 277:24609-24617.
12. Huang, I. C., B. J. Bosch, F. Li, W. Li, K. H. Lee, S. Ghiran, N. Vasilieva, T. S. Dermody, S. C. Harrison, P. R. Dormitzer, M. Farzan, P. J. Rottier, and H. Choe. 2006. SARS Coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J. Biol. Chem. 281:3198-3203.
13. Ishidoh, K., S. Taniguchi, and E. Kominami. 1997. Egr family member proteins are involved in the activation of the cathepsin L gene in v-src- transformed cells. Biochem. Biophys. Res. Commun. 238:665-669.
14. Kirschke, H., A. J. Barrett, and N. D. Rawlings. 1995. Proteinases 1: lysosomal cysteine proteinases. Protein Profile 2:1581-1643.
15. Kizhatil, K., and L. M. Albritton. 1997. Requirements for different components of the host cell cytoskeleton distinguish ecotropic murine leukemia virus entry via endocytosis from entry via surface fusion. J. Virol. 71:7145-7156.
16. Lavillette, D., A. Ruggieri, S. J. Russell, and F. L. Cosset. 2000. Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments. J. Virol. 74:295-304.
17. McClure, M. O., M. A. Sommerfelt, M. Marsh, and R. A. Weiss. 1990. The pH independence of mammalian retrovirus infection. J. Gen. Virol. 71:767-773.
18. Menendez-Arias, L., I. T. Weber, and S. Oroszlan. 1995. Mutational analysis of the substrate binding pocket of murine leukemia virus protease and comparison with human immunodeficiency virus proteases. J. Biol. Chem. 270:29162-29168.
19. Montase, M., G. Lalmanach, and L. Mach. 2002. CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells. Biol. Chem. 383:1305-1308.
20. Niman, H. L., and J. H. Elder. 1982. Structural analysis of Rauscher virus Gp70 using monoclonal antibodies: sites of antigenicity and P15(E) linkage. Virology 123:187-205.
21. Pager, C. T., and R. E. Dutch. 2005. Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein. J. Virol. 79:12714-12720.
22. Schornberg, K., S. Matsuyama, K. Kabsch, S. Delos, A. Bouton, and J. White. 2006. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J. Virol. 80:4174-4178.
23. Simkovic, D., N. Valentova, and V. Thurzo. 1962. An in vitro system for the detection of the Rous sarcoma virus in the cells of the rat tumour XC. Neoplasma 9:104-106.
24. Simmons, G., D. N. Gosalia, A. J. Rennekamp, J. D. Reeves, S. L. Diamond, and P. Bates. 2005. Inhibitors of cathepsin L prevent severe acute respiratory syndrome Coronavirus entry. Proc. Natl. Acad. Sci. USA 102:11876-11881.
25. Stearns, N. A., J. M. Dong, J. X. Pan, D. A. Brenner, and G. G. Sahagian. 1990. Comparison of cathepsin L synthesized by normal and transformed cells at the gene, message, protein, and oligosaccharide levels. Arch. Biochem. Biophys. 283:447-457.
26. Stetina, R., J. Svoboda, and O. Mach. 1975. Long-term preservation of transfecting activity of DNA isolated from rat virogenic XC cells transformed by Prague strain of Rous sarcoma virus. Folia Biol. 21:334-339.
27. Svoboda, J., P. Chyle, D. Simkovic, and I. Hilgert. 1963. Demonstration of the absence of infectious Rous virus in rat tumour XC, whose structurally intact cells produce Rous sarcoma when transferred to chicks. Folia Biol. 9:77-81.
28. Turk, B., V. Turk, and D. Turk. 1997. Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. Biol. Chem. 378:141-150.
29. Turk, V., B. Turk, and D. Turk. 2001. Lysosomal cysteine proteases: facts and opportunities. EMBO J. 20:4629-4633.
30. Wilson, G. J., E. L. Nason, C. S. Hardy, D. H. Ebert, J. D. Wetzel, B. V. V. Prasad, and T. S. Dermody. 2002. A single mutation in the carboxy terminus of reovirus outer-capsid protein sigma 3 confers enhanced kinetics of sigma 3 proteolysis, resistance to inhibitors of viral disassembly, and alterations in sigma 3 structure. J. Virol. 76:9832-9843.
31. Zavorotinskaya, T., and L. M. Albritton. 1999. Failure To cleave murine leukemia virus envelope protein does not preclude its incorporation in virions and productive virus-receptor interaction. J. Virol. 73:5621-5629.